Publicaciones en las que colabora con JAVIER VAQUERO RODRÍGUEZ (23)

2024

  1. Experimental Model of Biliary Tract Cancers: Subcutaneous Xenograft of Human Cell Lines in Immunodeficient Nude Mice

    Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 87-98

2023

  1. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

    Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480

  2. Intrinsic cancer cell phosphoinositide 3-kinase δ regulates fibrosis and vascular development in cholangiocarcinoma

    Liver International, Vol. 43, Núm. 12, pp. 2776-2793

  3. TGFβ-induced circLTBP2 predicts a poor prognosis in intrahepatic cholangiocarcinoma and mediates gemcitabine resistance by sponging miR-338-3p

    JHEP Reports, Vol. 5, Núm. 12

2022

  1. Genetic alterations shaping tumor response to anti-EGFR therapies

    Drug Resistance Updates, Vol. 64

  2. Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 724-734

2021

  1. Cholangiopathy aggravation is caused by VDR ablation and alleviated by VDR-independent vitamin D signaling in ABCB4 knockout mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1867, Núm. 4

  2. The tgf-β pathway: A pharmacological target in hepatocellular carcinoma?

    Cancers, Vol. 13, Núm. 13

  3. Zinc Finger E-Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor–Stroma Paracrine Signaling

    Hepatology, Vol. 74, Núm. 6, pp. 3194-3212

2020

  1. Cold-atmospheric plasma induces tumor cell death in preclinical in vivo and in vitro models of human cholangiocarcinoma

    Cancers, Vol. 12, Núm. 5

2019

  1. Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance

    Liver International, Vol. 39, Núm. S1, pp. 43-62

2018

  1. MicroRNA-506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation

    Hepatology, Vol. 67, Núm. 4, pp. 1420-1440

2016

  1. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

    Nature Reviews Gastroenterology and Hepatology, Vol. 13, Núm. 5, pp. 261-280

2015

  1. E-cadherin, guardian of liver physiology

    Clinics and Research in Hepatology and Gastroenterology, Vol. 39, Núm. 1, pp. 3-6

2013

  1. Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1833, Núm. 10, pp. 2212-2219

  2. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition

    Biochemical Pharmacology, Vol. 86, Núm. 7, pp. 926-939

  3. Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib

    Hepatology, Vol. 58, Núm. 3, pp. 1065-1073

  4. FXR-dependent and -independent interaction of glucocorticoids with the regulatory pathways involved in the control of bile acid handling by the liver

    Biochemical Pharmacology, Vol. 85, Núm. 6, pp. 829-838

  5. Papel del receptor nuclear de ácidos biliares NR1H4 (“farnesoid X receptor”, FXR) en el control de la expresión de genes implicados en el desarrollo de quimiorresistencia. Características funcionales de sus isoformas

    Papel del receptor nuclear de ácidos biliares NR1H4 (“farnesoid X receptor”, FXR) en el control de la expresión de genes implicados en el desarrollo de quimiorresistencia. Características funcionales de sus isoformas

2012

  1. Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta

    Molecular Pharmacology, Vol. 81, Núm. 2, pp. 273-283